However, we also detected EZH2 binding sites in AT/RT-unique DMRs in DE genes such as NEUROG1 and TCEA3, which are shown to be down-regulated in cancer and are relevant for early development (Park et al, 2013). The gene discussed is EZH2; the disease is cancer.